申请人:Bristol-Myers Squibb Company
公开号:US20160130299A1
公开(公告)日:2016-05-12
Tubulysin analogs of the formula (I)
where R
1
, R
2
R
3
, R
4
, R
5
, R
6
, R
7
, and Y are as defined herein, are anti-mitotic agents that can be used in the treatment of cancer, especially when conjugated to a targeting moiety.
管素类似物公式(I),其中R1、R2、R3、R4、R5、R6、R7和Y如本文所述定义,是一种抗有丝分裂剂,可用于癌症治疗,特别是在与靶向部分结合时。